Adrenal disease

Delayed Bone Maturation and Extended Growth Phase as Distinctive Features of 17α‐Hydroxylase/17,20‐Lyase Deficiency: A Retro‐Prospective Study of a Large Patient Cohort

Clin Endocrinol (Oxf)Published Retrospective and prospective cohort study

Authors' conclusion

In this large CYP17D cohort, we verified that the prolonged hypoestrogenism that led to delayed or absent puberty was associated with decreased bone age, lower stature in childhood and adolescence, missed growth spurts, an extended growth phase, and greater final heights with frequent eunuchoid appearance.

Study context

Population
Brazilian patients with combined 17-hydroxylase/17,20-lyase deficiency (CYP17D) treated at the Federal University of São Paulo Medical School and other Endocrine Reference Centres in Brazil
Participants
88 patients
Outcome
Growth, bone maturation and body proportions
Methodological detailsmulticentre
  • Multicentre

Main finding

As reported in the abstract

Median chronological age at diagnosis, non-adult patients (range 10-20 years; n = 41)
15.8 years
Median bone age at diagnosis, non-adult patients (7.5-15 years; n = 25)
11 years
Delay of ≥ 2 years in bone age
92.5%
Height in 30 patients (130-171.5 cm)
157 cm
Height Z-score in 30 patients (−3.0 to +1.6)
−0.4
Final height ≥50th percentile, of 51 patients (25 XY, 14 XX)
77%
Final height ≥90th percentile, of 51 patients (14 XY, 6 XX)
39%
Final height ≤25th percentile, of 51 patients (1 XY, 3 XX)
8%
Lower Z-scores during childhood and adolescence (plausibly missed growth spurt), of 42 patients with data
11 (26%)

Observational data: associations, not effects.

Original publication

Delayed Bone Maturation and Extended Growth Phase as Distinctive Features of 17α‐Hydroxylase/17,20‐Lyase Deficiency: A Retro‐Prospective Study of a Large Patient Cohort. Clin Endocrinol (Oxf). Published 11 May 2025. doi:10.1111/cen.15261

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.